Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

=================

CHAMPIONS TACKLING MS - AWARDS Dinner, Honoring Aaron Boster, MD and Jon e. Glaser, DDS - now open for registration. Visit www.events.msvn.org

Wednesday, April 5, 2017

Free iConquerMS™ T-Shirts!


                                                                  
  
Click here to receive MS news via e-mail



Free iConquerMS™ T-Shirts!

by Laura

Want a free iConquerMS T-shirt?

It’s simple and easy....
If you join iConquerMS before Friday, April 14, we will send you an iConquerMS  t-shirt for free. We will even pay the postage to anywhere in the US.
iConquerMS™ is facing a deadline for enrolling people in our online registry of people affected by MS, (and their friends and family as controls)  and we need you to join us today.

You've already joined iConquerMS but still want a shirt? 

Recruit one other person to join iConquerMS and when they join....
We will send you and them an iConquerMS t-shirt! There is a spot in the registration where people can tell us how they heard about iConquerMS and they can put your name in that space to make sure you get your free t-shirt. This means we will pay the postage twice!

How can you get your own free iConquerMS t-shirt?

Go to  www.iconquerms.org and click on the button that says JOIN NOW and follow the prompts. 
You can learn more while there about who we are and how your health information will help advance MS research for the people who matter most – you and me!!
Thanks,
Laura
PS - Be sure to share this link with others!

MS Views and News
Providing educational information, resources and services for those affected by MS, globally

Tuesday, April 4, 2017

Teva Receives Positive Outcome for COPAXONE® 40 mg/ml 3 Times Weekly Label in Europe


                                                                  
  
Click here to receive MS news via e-mail

European News
AMSTERDAM--()--Teva Pharmaceutical Industries Ltd. today announced that it has received a positive outcome through the variation procedure to remove the pregnancy contraindication from the European label for (glatiramer acetate injection) COPAXONE® 40 mg/ml 3 times weekly. The product was originally authorized through a decentralized procedure in Europe. An equivalent change has already been approved for COPAXONE® 20 mg/ml in December 2016.
According to the European Multiple Sclerosis Platform (EMSP) around 700,000 people in Europe are affected by Multiple Sclerosis (MS), with a 2:1 ratio between women and men. MS is more common among women of childbearing age compared with any other age group with the average age of diagnosis approximately 30 years, with ~43% of the women starting a family after diagnosis.
The removal of the pregnancy contraindication follows a Positive Variation Assessment Report issued by the United Kingdom's Medicines and Healthcare Products Regulatory Agency (MHRA; Reference Member State), and agreed by all Concerned Member States (CMS) in Europe, that were involved in the procedure. Granting of national approvals by all involved EU Member States will happen in the near future. COPAXONE® is indicated for the treatment of patients with relapsing forms of multiple sclerosis (RMS).

MS Views and News is MAKING an IMPACT on those affected by Multiple Sclerosis

Gene interaction tied to risk of developing multiple sclerosis


                                                                  
  
Click here to receive MS news via e-mail

By Nathan Luzum | Monday, April 3

thinkstockphotos179062209 Courtesy of Duke Photography




Variations in two genes could significantly increase the odds of developing multiple sclerosis, according to a new study by a team of Duke researchers.
The scientists discovered a new interaction between a gene called IL7R—which past studies have demonstrated contributes to the likelihood of developing MS—and a gene that plays an important role in regulating it, called DDX39B. They hypothesized that a variation in these genes would produce a different protein—one more likely to cause MS.
“If you happen to be an individual that has the variants of both genes, you have a much higher chance of developing MS,” said Mariano Garcia-Blanco, co-lead author of the study and chair of the department of molecular biology and biochemistry at the University of Texas Medical Branch at Galveston.
Garcia-Blanco explained that the study's research focused on controlling the expression of "soluble IL7R," or the soluble form of a receptor that is important in activating the immune cells causing the neural damage associated with MS. 
The difference between soluble IL7R and the standard IL7R protein is a portion of a gene known as an exon, which is the sequence of a gene's DNA that contains information about the coding for a protein sequence. Garcia-Blanco explained that the same gene could produce multiple versions of a protein in a process known as alternative splicing.
“What alternative splicing does is akin to what an editor in the film industry can do,” he said.

MS Views and News is MAKING an IMPACT on those affected by Multiple Sclerosis

Monday, April 3, 2017

Trailblazing MS doctor William Sheremata dies just after drug’s FDA approval


                                                                  
  
Click here to receive MS news via e-mail

Stu's Views - Dr. Sheremata will be missed -- It was his reconfirming diagnosis that proved that I had Multiple Sclerosis and it was him, that made me know that I had to be my own patient advocate.
~~~ -~ Stuart Schlossman    ----        G-D bless you!   ----- 

Please read the information showing below

Dr. William Sheremata’s research and clinical trials at the University of Miami’s medical school led to the FDA approval of a new drug in the fight against multiple sclerosis.  
Dr. William Sheremata’s research and clinical trials at the University of Miami’s medical school led to the FDA approval of a new drug in the fight against multiple sclerosis.University of Miami Miller School of Medicine




Read more here: http://www.miamiherald.com/news/local/obituaries/article142099539.html#storylink=cpy
  

BY HOWARD COHEN - hcohen@miamiherald.com
READ MORE



MS Views and News is MAKING an IMPACT on those affected by Multiple Sclerosis